|
1
|
Leal MTBC, Passos LSA, Guarçoni FV, de
Souza Aguiar JM, da Silva RBR, de Paula TMN, Santos RFD, Nassif
MCL, Gomes NFA, Tan TC and Nunes MCP: Rheumatic heart disease in
the modern era: Recent developments and current challenges. Rev Soc
Bras Med Trop. 52(e20180041)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mirabel M, Narayanan K, Jouven X and
Marijon E: Cardiology patient page. Prevention of acute rheumatic
fever and rheumatic heart disease. Circulation. 130:e35–e37.
2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wu XD, Zeng ZY, Gong DP, Wen JL and Huang
F: Potential involvement of S1PR1/STAT3 signaling pathway in
cardiac valve damage due to rheumatic heart disease. Biotech
Histochem. 94:398–403. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wang Y, He G, Tang H, Shi Y, Kang X, Lyu
J, Zhu M, Zhou M, Yang M, Mu M, et al: Aspirin inhibits
inflammation and scar formation in the injury tendon healing
through regulating JNK/STAT-3 signalling pathway. Cell Prolif.
52(e12650)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liu CH, Hua N, Fu X, Pan YL, Li B and Li
XD: Metformin regulates atrial SK2 and SK3 expression through
inhibiting the PKC/ERK signaling pathway in type 2 diabetic rats.
BMC Cardiovasc Disord. 18(236)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sung JY and Choi HC: Nifedipine inhibits
vascular smooth muscle cell proliferation and reactive oxygen
species production through AMP-activated protein kinase signaling
pathway. Vascul Pharmacol. 56:1–8. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jiang L, Wei XF, Yi DH, Xu P, Liu H, Chang
Q, Yang SM, Li ZF, Gao HB and Hao GJ: Synergistic effects of cyclic
strain and Th1-like cytokines on tenascin-C production by rheumatic
aortic valve interstitial cells. Clin Exp Immunol. 155:216–223.
2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zeisberg M, Hanai J, Sugimoto H, Mammoto
T, Charytan D, Strutz F and Kalluri R: BMP-7 counteracts
TGF-beta1-induced epithelial-to-mesenchymal transition and reverses
chronic renal injury. Nat Med. 9:964–968. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Yang L, Tang L, Dai F, Meng G, Yin R, Xu X
and Yao W: Raf-1/CK2 and RhoA/ROCK signaling promote TNF-α-mediated
endothelial apoptosis via regulating vimentin cytoskeleton.
Toxicology. 389:74–84. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Vicente-Steijn R, Kelder TP, Tertoolen LG,
Wisse LJ, Pijnappels DA, Poelmann RE, Schalij MJ, deRuiter MC,
Gittenberger-de Groot AC and Jongbloed MRM: RHOA-ROCK signalling is
necessary for lateralization and differentiation of the developing
sinoatrial node. Cardiovasc Res. 113:1186–1197. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li L, Zhao Q and Kong W: Extracellular
matrix remodeling and cardiac fibrosis. Matrix Biol. 68-69:490–506.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Dziki JL and Badylak SF: Extracellular
matrix for myocardial repair. Adv Exp Med Biol. 1098:151–171.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Diamantino Soares AC, Araújo Passos LS,
Sable C, Beaton A, Ribeiro VT, Gollob KJ, Dutra WO and Nunes MCP:
Circulating cytokines predict severity of rheumatic heart disease.
Int J Cardiol. 289:107–109. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Rehman S, Akhtar N, Saba N, Munir S, Ahmed
W, Mohyuddin A and Khanum A: A study on the association of
TNF-α(-308), IL-6(-174), IL-10(-1082) and IL-1Ra(VNTR) gene
polymorphisms with rheumatic heart disease in Pakistani patients.
Cytokine. 61:527–531. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Deng H, Xue YM, Zhan XZ, Liao HT, Guo HM
and Wu SL: Role of tumor necrosis factor-alpha in the pathogenesis
of atrial fibrillation. Chin Med J (Engl). 124:1976–1982.
2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Guilherme L, Cury P, Demarchi LM, Coelho
V, Abel L, Lopez AP, Oshiro SE, Aliotti S, Cunha-Neto E,
Pomerantzeff PMA, et al: Rheumatic heart disease: Proinflammatory
cytokines play a role in the progression and maintenance of
valvular lesions. Am J Pathol. 165:1583–1591. 2004.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li M, Yi X, Ma L and Zhou Y: Hepatocyte
growth factor and basic fibroblast growth factor regulate atrial
fibrosis in patients with atrial fibrillation and rheumatic heart
disease via the mitogen-activated protein kinase signaling pathway.
Exp Ther Med. 6:1121–1126. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang D, Liu X, Chen X, Gu J, Li F, Zhang
W and Zheng Y: Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in
atrial fibrosis of patients with chronic atrial fibrillation and
rheumatic mitral valve disease. Cardiology. 129:216–223.
2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhao Z, He D, Ling F, Chu T, Huang D, Wu H
and Ge J: CD4+ T cells and TGFβ1/MAPK signal pathway
involved in the valvular hyperblastosis and fibrosis in patients
with rheumatic heart disease. Exp Mol Pathol.
114(104402)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lee S, Rauch J and Kolch W: Targeting MAPK
signaling in cancer: Mechanisms of drug resistance and sensitivity.
Int J Mol Sci. 21(1102)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang P, Wang W, Wang X, Wang X, Song Y,
Zhang J and Zhao H: Focal adhesion kinase mediates atrial fibrosis
via the AKT/S6K signaling pathway in chronic atrial fibrillation
patients with rheumatic mitral valve disease. Int J Cardiol.
168:3200–3207. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Narikawa M, Umemura M, Tanaka R, Fujita T,
Yokoyama U, Ishigami T, Kimura K, Tamura K and Ishikawa Y: Acute
hyperthermia inhibits TGF-β1-induced cardiac fibroblast activation
via suppression of Akt signaling. Sci Rep. 8(6277)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang L, Zhang N, Tang X, Liu F, Luo S and
Xiao H: Increased α-actinin-2 expression in the atrial myocardium
of patients with atrial fibrillation related to rheumatic heart
disease. Cardiology. 135:151–159. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hu HH, Chen DQ, Wang YN, Feng YL, Cao G,
Vaziri ND and Zhao YY: New insights into TGF-β/Smad signaling in
tissue fibrosis. Chem Biol Interact. 292:76–83. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Vincent T, Neve EPA, Johnson JR, Kukalev
A, Rojo F, Albanell J, Pietras K, Virtanen I, Philipson L, Leopold
PL, et al: A SNAIL1-SMAD3/4 transcriptional repressor complex
promotes TGF-beta mediated epithelial-mesenchymal transition. Nat
Cell Biol. 11:943–950. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Thuault S, Tan EJ, Peinado H, Cano A,
Heldin CH and Moustakas A: HMGA2 and Smads co-regulate SNAIL1
expression during induction of epithelial-to-mesenchymal
transition. J Biol Chem. 283:33437–33446. 2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Guo F, Yi X, Li M, Fu J and Li S: Snail1
is positively correlated with atrial fibrosis in patients with
atrial fibrillation and rheumatic heart disease. Exp Ther Med.
14:4231–4237. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Foulquier S, Daskalopoulos EP, Lluri G,
Hermans KCM, Deb A and Blankesteijn WM: WNT signaling in cardiac
and vascular disease. Pharmacol Rev. 70:68–141. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Aisagbonhi O, Rai M, Ryzhov S, Atria N,
Feoktistov I and Hatzopoulos AK: Experimental myocardial infarction
triggers canonical Wnt signaling and endothelial-to-mesenchymal
transition. Dis Model Mech. 4:469–483. 2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chen A, Wen J, Lu C, Lin B, Xian S, Huang
F, Wu Y and Zeng Z: Inhibition of miR-155-5p attenuates the
valvular damage induced by rheumatic heart disease. Int J Mol Med.
45:429–440. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hu YS, Han X and Liu XH: STAT3: A
potential drug target for tumor and inflammation. Curr Top Med
Chem. 19:1305–1317. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Liu X, Hu H, Fan H, Zuo D, Shou Z, Liao Y,
Nan Z and Tang Q: The role of STAT3 and AhR in the differentiation
of CD4+ T cells into Th17 and Treg cells. Medicine
(Baltimore). 96(e6615)2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Bas HD, Baser K, Yavuz E, Bolayir HA,
Yaman B, Unlu S, Cengel A, Bagriacik EU and Yalcin R: A shift in
the balance of regulatory T and T helper 17 cells in rheumatic
heart disease. J Investig Med. 62:78–83. 2014.PubMed/NCBI View Article : Google Scholar
|
